People · Operator
Named in public records as an officer, director or promoter · active 2012–2023 · Biotechnology, Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Centrexion Therapeutics Corp | — | Biotechnology | Series C | $202.0M | $35.3M | 2013 |
| Diffusion Pharmaceuticals Inc. | — | Pharmaceuticals | Series C | $140.0M | $26.3M | 2014 |
| Zephyr AI, Inc. | — | Biotechnology | Series D+ | $129.7M | $1.5B | 2022 |
| InspireMD, Inc. | — | Other Health Care | Series C | $117.2M | $248.3M | 2012 |
| Edge Therapeutics, Inc. | — | Pharmaceuticals | Series C | $72.1M | $2.0B | 2012 |
| Mig Irc, Llc | — | Other Health Care | Seed | $5.7M | $86.0M | 2012 |
Sol Barer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sol Barer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Isaac Blech | 3 | 14 |
| Sol J. Barer | 3 | 6 |
| Isaac J. Blech | 2 | 3 |
| James J. Loughlin | 2 | 2 |
| Arnold Oronsky | 1 | 10 |
| Michael Berman | 1 | 7 |
| Steve Murray | 1 | 7 |
| Arnold L. Oronsky | 1 | 6 |
| Mark Simon | 1 | 6 |
| David Morgan | 1 | 6 |
| MICHAEL J. WARD | 1 | 5 |
| James Barry | 1 | 5 |
| William Kelly | 1 | 5 |
| PAUL FELLER | 1 | 4 |
| Asher Holzer | 1 | 4 |
| Moncef Slaoui | 1 | 3 |
| Nelson Stacks | 1 | 3 |
| Rex Bright | 1 | 3 |
| Eli Bar | 1 | 3 |
| Grant Verstandig | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.